Eton Pharmaceuticals, Inc. (ETON)
NASDAQ·Healthcare·Biotechnology
$24.07
+2.64%
Mkt Cap $628.09M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | $19.98M | $21.28M | +6.53% | $0.12 | $0.05 | -58.33% | — | — |
| Q4 2025 Nov 6, 2025 | $20.47M | $22.46M | +9.70% | $0.16 | -$0.07 | -143.75% | — | — |
| Q3 2025 Aug 7, 2025 | $20.47M | $18.93M | -7.55% | -$0.01 | -$0.10 | -900.00% | — | — |
| Q2 2025 May 13, 2025 | $15.13M | $17.28M | +14.22% | $0.09 | $0.07 | -22.22% | — | — |
| Q1 2025 Mar 18, 2025 | $14.33M | $11.65M | -18.73% | -$0.02 | -$0.02 | +0.00% | — | — |
| Q4 2024 Nov 12, 2024 | $10.53M | $10.32M | -1.96% | $0.00 | $0.02 | +400.00% | — | — |
| Q3 2024 Aug 8, 2024 | $9.69M | $9.07M | -6.36% | -$0.07 | -$0.12 | -71.43% | — | — |
| Q2 2024 May 9, 2024 | $8.80M | $7.97M | -9.48% | -$0.07 | -$0.03 | +57.14% | — | — |
| Q1 2024 Mar 14, 2024 | $7.70M | $7.31M | -5.03% | -$0.04 | -$0.09 | -125.00% | — | — |
| Q4 2023 Nov 9, 2023 | $6.26M | $7.03M | +12.27% | -$0.10 | -$0.02 | +80.00% | — | — |
| Q3 2023 Aug 10, 2023 | $10.09M | $12.00M | +18.90% | -$0.09 | $0.15 | +266.67% | — | — |
| Q2 2023 May 11, 2023 | $6.51M | $5.30M | -18.53% | -$0.14 | -$0.10 | +28.57% | — | — |
| Q1 2023 Mar 16, 2023 | $4.56M | $8.50M | +86.36% | $0.01 | $0.04 | +300.00% | — | — |
| Q4 2022 Nov 10, 2022 | $3.05M | $3.22M | +5.58% | -$0.15 | -$0.12 | +20.00% | — | — |
| Q3 2022 Aug 11, 2022 | $7.80M | $7.36M | -5.67% | -$0.01 | -$0.06 | -300.00% | — | — |
| Q2 2022 May 12, 2022 | $2.04M | $2.18M | +6.67% | -$0.08 | -$0.21 | -162.50% | — | — |
| Q1 2022 Mar 16, 2022 | — | $6.09M | — | $0.19 | $0.04 | -78.95% | — | — |
| Q4 2021 Nov 15, 2021 | $663.96K | $775.00K | +16.72% | -$0.14 | -$0.24 | -71.43% | — | — |
| Q3 2021 Aug 16, 2021 | $4.76M | $3.07M | -35.57% | -$0.14 | -$0.08 | +42.86% | — | — |
| Q2 2021 May 13, 2021 | $12.05M | $11.90M | -1.27% | $0.19 | $0.19 | +0.00% | — | — |